about
Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune DysfunctionRole of multifaceted regulators in cancer glucose metabolism and their clinical significanceGlucose metabolism in gastric cancer: The cutting-edgeLactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic RelevanceHow, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activityTargeted Therapies in Adult B-Cell MalignanciesProgress toward overcoming hypoxia-induced resistance to solid tumor therapyMolecular pathways: trafficking of metabolic resources in the tumor microenvironmentRedox control of glutamine utilization in cancerNovel therapeutic targets of tumor metabolismHeterogeneity of glycolysis in cancers and therapeutic opportunities.Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier ModelingThe HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-BromopyruvateReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effectROS homeostasis and metabolism: a critical liaison for cancer therapyEvidence of cancer-promoting roles for AMPK and related kinasesContribution of acidic extracellular microenvironment of cancer-colonized bone to bone painCryptosporidium Lactate Dehydrogenase Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Target for Developing TherapeuticsIdentification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell LinesDroplet Microfluidic Platform for the Determination of Single-Cell Lactate Release.A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung AdenocarcinomaLactate Chemical Exchange Saturation Transfer (LATEST) Imaging in vivo A Biomarker for LDH ActivityMR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.Targeting MYC Dependence by Metabolic Inhibitors in CancerIntratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.Cancer heterogeneity is not compatible with one unique cancer cell metabolic mapMPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect.Glycolytic reliance promotes anabolism in photoreceptors.Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasisReprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?Fibroblast heterogeneity in the cancer wound.Restricting carbohydrates to fight head and neck cancer-is this realistic?Attacking the supply wagons to starve cancer cells to death.Organization of enzyme concentration across the metabolic network in cancer cellsLUD, a new protein domain associated with lactate utilization.Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cellsDichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma.Modulation of intracellular calcium levels by calcium lactate affects colon cancer cell motility through calcium-dependent calpain.Acidic microenvironment and bone pain in cancer-colonized boneMetabolic Signatures of Human Breast Cancer.
P2860
Q26749333-2CAE2E49-44F3-4D85-87D0-B4B9FC6A0727Q26765039-01329CF4-7049-493E-8561-979D72C7EAF3Q26766098-E8D3B788-2C7B-4731-BAF6-A8352867A51EQ26766711-F59C9061-A793-4710-B9BD-7DD61EE3E4D2Q26775999-38FBBBDE-BFA2-4E56-9BAC-078A87FAE81BQ26783195-72C0AD13-58B8-4D3C-A000-B423BBA7A768Q26796405-2D8D25C3-FDC1-4499-BEC8-7179F00801FBQ26825620-9B8A5162-C3A4-40C4-AC2D-F49708A8F53EQ27005615-1CDAF900-D88C-490B-9F25-64ED3BC4CFAFQ27005930-ED15679E-4381-46F2-9C03-6D34F1FA3B8CQ27693375-A1FC1022-5386-4F93-8BE9-D60EA774A7E6Q28072654-19CA86F0-050B-458B-9611-AC5590E06751Q28073392-B5F148C6-2C58-4E42-A1C0-3D121731E081Q28077883-42E536D3-6B23-4FF1-ABD5-706CC349CB8CQ28080316-62B7AB14-12B6-4013-8067-F22D2E40904BQ28083964-1AE5CE81-8996-4F25-A6CB-056473F74A6BQ28085753-4B093961-99E4-4FF1-9CD4-FC7C07D848EAQ28550913-B66E053D-BBAB-4660-AEE2-D8262E027AE4Q28553394-2EE2307F-961D-4510-9BFC-DE92F4A4EE44Q30734408-942C5649-9294-47A2-8B34-57CA0964411DQ31018336-0360F3BF-B6A1-4486-A6D3-E247D7AC7319Q31038774-B1B903F5-4845-45A0-BDF9-5AB0D002FA72Q31137181-0C5F7556-5421-4A06-9C80-51C0C2F2C176Q33608493-3C71B9C8-43FB-4F44-97CE-BA79341C30F3Q33618507-C666F32F-113C-44D1-BA40-88F48E71FC88Q33721222-352B5CFC-B72E-4067-836A-A9BDC596C64EQ33866466-88FFF2DC-B808-4739-B17D-27DB4973042DQ33879266-FA8B91AF-175F-4344-B233-C875FB708333Q33884709-E3CC8F39-47FE-4FF9-A41E-146D4FD6ED65Q33917658-1590BD22-D6C5-48F6-BE25-0B2BF7E6CA34Q33964324-82839FF5-1534-4679-9D24-68523D987556Q34340949-E08E63B6-E066-4169-99F2-9725F15E83F6Q34516773-73DDF81D-E783-4BD1-83DA-69E89466DBFBQ35013401-69F962D7-0210-4A26-95F1-4ACE53129F44Q35052401-4B56D111-1038-40E6-85F5-323E41B51C49Q35068068-D6407A34-7B0B-48A1-8504-9C12C5129429Q35176364-2EB092E6-449A-4C87-B0E6-D53CAACBCCE5Q35550785-C372B146-F8DF-47E8-B451-4F91670C54DAQ35575632-C0F9CD8F-538C-4E98-B586-B2ACA1CCB621Q35627478-4B713A79-7B9D-434F-90D1-715C3CCD4B8D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting lactate metabolism for cancer therapeutics.
@en
type
label
Targeting lactate metabolism for cancer therapeutics.
@en
prefLabel
Targeting lactate metabolism for cancer therapeutics.
@en
P2860
P356
P1476
Targeting lactate metabolism for cancer therapeutics.
@en
P2093
Joanne R Doherty
John L Cleveland
P2860
P304
P356
10.1172/JCI69741
P407
P577
2013-09-03T00:00:00Z